Abstract
Vimentin, p53 protein and cathepsin D positivity were assessed by immunohistochemistry, and oestrogen receptor (ER) by an enzyme immunoassay, in invasive lobular carcinomas (LC) of the breast. While vimentin was positive in only 5% (3/57) and p53 protein was positive only in 3% (2/63), cathepsin D was expressed in 86% (48/56) and ER in 78% (25/32). Classical LC were negative for p53 protein and all except one were cathepsin D positive. These results are in contrast to invasive ductal breast carcinomas (DC), where the reported average incidence of vimentin and p53 protein is much higher (19% and 33% respectively) and that of cathepsin D and ER lower (63% and 67% respectively). Thus lack of expression of vimentin and lack of p53 positivity together with high incidence of expression of cathepsin D and ER are more often associated with lobular than with ductal differentiation of invasive breast cancer. The results show that LC, distinguished morphologically, can further be defined by its immunohistochemical profile. This in turn may point to underlying biological differences between LC and DC.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Allred D, Clark G, Elledge R, Fuqua S, Brown R, Chamness G, Osborne C, McGuire W (1993) Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancer. J Natl Cancer Inst 85:200–206
Antoniades K, Spector M (1979) Correlation of estrogen receptor levels with histology and cytomorphology in human mammary cancer. Am J Clin Pathol 71:497–503
Bailey AJ, Sloan JP, Trichey BS, Omerod MG (1982) An immunocytochemical study of alpha-lactalbumin in human breast tissue. J Pathol 137:13–23
Cattoretti G, Andreola S, Clemente C, D'Amoto L, Rilbe F (1988) Vimentin and p53 expression on epidermal growth factor receptor-positive, oestrogen receptor-negative breast carcinomas. Br J Cancer 57:353–357
Davidoff A, Humphrey P, Iglehart J, Marks JR (1991) Genetic basis for p53 overexpression in human breast cancer. Proc Natl Acad Sci USA 88:5006–5010
DiConstanzo D, Rosen PP, Gareen I, Franklin S, Lesser M (1990) Prognosis in infiltrating lobular carcinoma. An analysis of “classical” and variant tumors. Am J Surg Pathol 14:12–23
Domagala W, Lasota J, Bartkowiak J, Weber K, Osborn M (1990a) Vimentin is preferentially expressed in human breast carcinomas with low estrogen receptor and high Ki-67 growth fraction. Am J Pathol 136:219–227
Domagal W, Wozniak L, Lasota J, Weber K, Osborn M (1990b) Vimentin is preferentially expressed in high grade ductal and medullary, but not in lobular breast carcinomas. Am J Pathol 137:1059–1064
Domagala W, Lasota J, Dukowicz A, Markiewski M, Striker G, Weber K, Osborn M (1990c) Vimentin expression appears to be associated with poor prognosis in node-negative ductal NOS breast carcinomas. Am J Pathol 137:1299–1304
Domagala W, Striker G, Szadowska A, Markiewski M, Weber K, Osborn M (1992) Cathepsin D in invasive ductal NOS breast carcinoma as defined by immunohistochemistry. No correlation with survival at 5 years. Am J Pathol 141:1003–1012
Domagala W, Harezga B, Szadowska A, Markiewski M, Weber K, Osborn M (1993) Nuclear p53 accumulates preferentially in medullary and high grade ductal but rarely in lobular breast carcinomas. Am J Pathol 142:669–674
Eusebi V, Pich A, Macchiorlatti E, Bussolati F (1977) Morphofunctional differentiation of lobular carcinoma of the breast. Histopathology 1:307–314
Garcia M, Duplay H, Cavaililles V, Derocq D, Delarue JC, Krebs B, Contesso G, Sancho-Garnier H, Richer G, Domergue J, Namer M, Rochefort H (1987) Immunohistochemical distribution of the 52K protein in mammary tumors: a marker associated with cell proliferation rather than with hormone responsiveness. J Steroid Biochem 27:439–445
Gould VE, Koukoulis GK, Jansson DS, Nagle RB, Franke WW, Moll R (1990) Coexpression patterns of vimentin and glial filament protein with cytokeratins in the normal hyperplastic, and neoplastic breast. Am J Pathol 137:1143–1155
Henry JA, McCarthy AL, Angus B, Westley BR, May FEB, Nicholson S, Cairns J, Harris AL, Horne CHW (1990) Prognostic significance of the estrogen-regulated protein cathepsin D in breast cancer. An immunohistochemical study. Cancer 65:265–271
Isola J, Visakorpi T, Holli K, Kallioniemi O-P (1992) Association of overexpression of tumor suppressor protein p53 with rapid cell proliferation and poor prognosis in node-negative breast cancer patients. J Natl Cancer Inst 84:1109–1114
Kuhajda FP, Offult LE, Mendelsohn G (1993) The distribution of carcinoembryonic antigen in breast carcinoma. Diagnostic and prognostic implications. Cancer 52:1257–1264
Lane DP, Benchimol S (1990) p53: oncogene or anti-ancogene? Genes Dev 4:1–8
Lesser ML, Rosen PP, Senie RT, Duthie K, Menendez-Botet CJ, Schwartz MK (1981) Estrogen and progesterone receptors in breast carcinoma. Correlations with epidemiology and pathology. Cancer 48:299–309
McCarty KS, Barton T, Fetter B, Woodard BH, Mossier JA, Reeves W, Daly J, Wilkinson WE (1980) Correlation of estrogen and progesterone receptors with histologic differentiation in mammary carcinoma. Cancer 46:2851–2858
Millis R, Girling A (1989) The breast. Diagnostic surgical pathology. In: Sternberg S (ed), Raven Press, New York, pp 253–313
Mohammed RH, Lakatua DJ, Haus E, Yasmineh WJ (1986) Estrogen and progesterone receptors in human breast cancer. Correlation with histologic subtype and degree of differentiation. Cancer 58:1076–1081
Nesland JM, Holm J, Johannessen JV (1985) Ultrastructural and immunohistochemical features of lobular carcinoma of the breast. J Pathol 145:39–52
Nesland JM, Grude TH, Ottestad L, Johannessen JV (1992) Invasive lobular carcinoma of the breast. The importance of an alveolar growth pattern. Pathol Annu 27/I:233–248
Osborn M, Debus E, Weber K (1984) Monoclonal antibodies specific for vimentin. Eur J Cell Biol 34:137–143
Rasmussen BB, Rose C, Thorpe SM, Hou-Jensen K., Daehnfeldt JL, Palshof T (1981) Histopathological characteristics and oestogen receptor content in primary breast carcinoma. Virchows Arch [A] 390:347–351
Raymond W, Leong AS-Y (1989a) Coexpression of cytokeratin and vimentin intermediate filament proteins in benign and neoplastic breast epithelium. J Pathol 157:299–306
Raymond W, Leong A-Y (1989b) Vimentin — a new prognostic parameter in breast carcinoma? J Pathol 158:107–114
Reiner A, Reiner G, Spona J, Schemper M, Holzner JH (1988) Histopathologic characterization of human breast cancer in correlation with estrogen receptor status. A comparison of immunocytochemical and biochemical analysis. Cancer 61:1149–1154
Rochefort H, Capony F, Garcia M (1990) Cathepsin D in breast cancer: from molecular and cellular biology to clinical applications. Cancer Cells 2:383–388
Rosen PP, Menendez-Botet C, Nisselbaum JS, Urban JA, Mike V, Frauchia A, Schwartz MK (1975) Pathological review of breast lesions analysed for estrogen receptor protein. Cancer Res 353:187–194
Shousha S, Backhous CM, Alghband-Zadeh J, Burn I (1986) Alveolar variant of invasive lobular carcinoma of the breast. A tumor rich in estrogen receptors. Am J Clin Pathol 85:1–5
Silfversward C, Gustaffson J-A, Gustaffson SA, Humla S, Nordensk B, Wallgren A, Wrange O (1980) Estrogen receptor concentrations in 269 cases of histologically classified human breast cancer. Cancer 45:2001–2005
Smith DB, Howell A, Wagstaff J (1987) Infiltrating lobular carcinoma of the breast: response to endocrine therapy and survival. Eur J Clin Oncol 23:979–982
Thor A, Moore DI, Edgerton S, Kawasaki E, Reihsaus E, Lynch H, Marcus J, Schwartz L, Chen L-C, Mayall BH, Smith HS (1992) Accumulation of p53 tumor suppressor gene protein: an independent marker of prognosis in breast cancers. J Natl Cancer Inst 84:845–855
Thorpe SM (1987) Monoclonal antibody technique for detection of estrogen receptors in human breast cancer: greater sensitivity and more accurate classification of receptor status than the dextran-coated charcoal method. Cancer Res 47:6572–6575
Walker RA (1979) The demonstration of alpha-lactalbumin in human breast carcinoma. J Pathol 129:37–42
Wellings SR, Jensen HM, Marcum RG (1975) Atlas of subgross pathology of the human breast with special reference to possible cancerous lesions. J Natl Cancer Inst 55:231–273
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Domagala, W., Markiewski, M., Kubiak, R. et al. Immunohistochemical profile of invasive lobular carcinoma of the breast: Predominantly vimentin and p53 protein negative, cathepsin D and oestrogen receptor positive. Vichows Archiv A Pathol Anat 423, 497–502 (1993). https://doi.org/10.1007/BF01606541
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01606541